Variant report

Variant	nsv10429
Chromosome Location	chr4:3676893-3678652
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-LRPAP1-2	chr4:3678330-3678408	ENSG00000250632
2	lnc-LRPAP1-2	chr4:3678330-3678408	XLOC_003861

Extended variants
information (count: 109 )
Associated
traits (count: 55 )

Variant overlapped rSNPs/rCNVs (count:109 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs573663105	chr4:3676917-3676918	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs147623537	chr4:3676924-3676925	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs73795840	chr4:3676929-3676930	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs149108713	chr4:3676940-3676941	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs62272067	chr4:3676979-3676980	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs187384995	chr4:3676980-3676981	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs575868024	chr4:3676989-3676990	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs544297702	chr4:3677004-3677005	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs189208961	chr4:3677044-3677045	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs530142190	chr4:3677057-3677058	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs557072784	chr4:3677097-3677098	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs547103730	chr4:3677104-3677105	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs62272068	chr4:3677106-3677107	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs528272244	chr4:3677113-3677114	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs551572915	chr4:3677119-3677120	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs73795841	chr4:3677127-3677128	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs116365220	chr4:3677128-3677129	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs373624642	chr4:3677174-3677175	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs181587757	chr4:3677197-3677198	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs535983157	chr4:3677210-3677211	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs61600890	chr4:3677213-3677214	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs112189920	chr4:3677215-3677216	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs185805259	chr4:3677216-3677217	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs114596924	chr4:3677218-3677219	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs575861005	chr4:3677223-3677224	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs544846018	chr4:3677226-3677227	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs111730951	chr4:3677227-3677228	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs115731341	chr4:3677249-3677250	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs73795842	chr4:3677268-3677269	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs200185526	chr4:3677272-3677273	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs533117171	chr4:3677276-3677277	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs386670767	chr4:3677277-3677278	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs559563909	chr4:3677278-3677279	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs200254044	chr4:3677279-3677280	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs532616300	chr4:3677280-3677281	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs386670768	chr4:3677284-3677285	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs551609676	chr4:3677286-3677287	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs190210504	chr4:3677289-3677290	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs530759572	chr4:3677296-3677297	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs181289780	chr4:3677303-3677304	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs186196390	chr4:3677304-3677305	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs376356300	chr4:3677326-3677327	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs546162227	chr4:3677370-3677371	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs191043411	chr4:3677377-3677378	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs182460271	chr4:3677428-3677429	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs141844542	chr4:3677479-3677480	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs557292510	chr4:3677483-3677484	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs538186890	chr4:3677485-3677486	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs115306843	chr4:3677493-3677494	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs575155901	chr4:3677494-3677495	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:55)

Disease	PMID	Source
Retinitis pigmentosa	18421352	CNVD
Wolf-Hirschhorn syndrome	19259404	CNVD
Bladder cancer	19242612	CNVD
Breast cancer	19242612	CNVD
Congenital anomalies of the kidney and urinary tract	19242612	CNVD
abnormal development	18461090	CNVD
Olfactory neuroblastoma	18408657	CNVD
Wilms tumour	21544195	CNVD
Melanoma	20688739	CNVD
Colorectal cancer	16272173	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17603634	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Neuroblastoma	18923191	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21785460	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	21399695	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Breast cancer	21509527	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Lung cancer	18438408	CNVD

Chromatin state (count:23 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:3658600-3678000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr4:3669400-3693400	Weak transcription	Right Atrium	heart
3	chr4:3670000-3677600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
4	chr4:3674200-3678800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
5	chr4:3676200-3677400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
6	chr4:3676400-3677600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
7	chr4:3677000-3677400	Enhancers	HUES6 Cell Line	embryonic stem cell
8	chr4:3677000-3677400	Enhancers	Spleen	Spleen
9	chr4:3677200-3677400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
10	chr4:3677200-3677400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
11	chr4:3677200-3678400	Bivalent Enhancer	Fetal Muscle Leg	muscle
12	chr4:3677400-3677600	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
13	chr4:3677400-3678000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr4:3677400-3678000	Weak transcription	Spleen	Spleen
15	chr4:3677400-3678200	Enhancers	H1 Cell Line	embryonic stem cell
16	chr4:3677400-3678200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
17	chr4:3677600-3678600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
18	chr4:3678000-3678200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
19	chr4:3678000-3678800	ZNF genes & repeats	Spleen	Spleen
20	chr4:3678000-3679000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
21	chr4:3678000-3679000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
22	chr4:3678200-3679400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
23	chr4:3678600-3679000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links